Table 2.
Group | Control (n = 18) | FTS (n = 17) | P value |
---|---|---|---|
Age (year) | 56.6 (50–65) | 55.1 (44–65) | 0.931 |
Sex | 1.000 | ||
Male | 14 (78%) | 13 (76%) | |
Female | 4 (22%) | 4 (24%) | |
ASA score | 0.877 | ||
ASA 1 | 10 (56%) | 9 (53%) | |
ASA 2 | 8 (44%) | 8 (47%) | |
BMI (kg/m2) | 25.6 (18.7–29.8) | 26.8 (18.5–30.0) | 0.832 |
FEV1 (l) | 2.8 (2.5–3.7) | 2.9 (2.5–3.9) | 1.000 |
T stage | 0.903 | ||
T2 | 12 (67%) | 11 (65%) | |
T3 | 6 (33%) | 6 (35%) | |
Operation side | 0.658 | ||
Left | 14 (78%) | 15 (88%) | |
Right | 4 (22%) | 2 (12%) | |
Pathology | 1.000 | ||
Squamous carcinoma | Cell 16 (89%) | 15 (88%) | |
Adenocarcinoma | 2 (11%) | 2 (12%) |
FEV1 forced expiratory volume in 1 s, ASA American Society of Anesthesiologists, BMI body mass index